Cardiac Pacemakers-Sowton EBLRn 13 (Johansson, 1966) while paced patients have a one-year mortality of only 10-15% (Chardack, 1967; Sowton, 1967) it seems likely that the number of paced patients in Britain will continue to increase rapidly. It is to be hoped that improvements in pacemaker design and manufacture will continue, and will be matched by an increasing standard of implantation and followup care.
8nz. med. J., 1968, 2, 13-16 it is now accepted that the rational treatment for chronic atrioventricular block is continuous pacing of the heart with an implanted pacemaker. The logic of this was first put into practice by Elmqvist and Senning (1960) and by Zoll and Linenthal (1960) , followed later that same year by Chardack et al. (1960) . Since 1962 implantable pacemakers have been Ised in Glasgow (Glass et al., 1963a (Glass et al., , 1963b Bain et al., 1967) and a variety of types tried. The earlier epicardial pacing systems were attended by a high rate of failure, necessitating in many cases two or more changes of pacemaker. In the last few years, however, advances in technology and increasing experience in the use of pacemakers have combined to produce more reliable generators and catheter electrode systems. Furthermore, the demonstration of the simplicity and effectiveness of the transvenous method of permanent cardiac pacing (Parsonnet et al., 1962 ; Siddons and Davies, 1963 ; Lagergren and Johansson, 1963) , requiring no thoracotomy, made the transvenous method immediately attractive. In 1964 we in Glasgow became impressed with the superiority of the Medtronic generator and bipolar electrode catheter for endocardial pacing, and since then have used this exclusively as the unit of choice for fixed-rate pacing.
Between (Table I) Persistent complete heart block was found in 32 patients and intermittent complete heart block in the remaining 12. Superimposed on these atrioventricular dissociations nine patients had developed dangerous tachyrhythmias, either before temporary pacing or during insertion of the temporary catheter electrode. Ventricular tachycardia occurred in five of these cases and bursts of multiple ventricular extrasystoles In four others. Of these nine patients three developed ventricular fibrillation and one asystole. In addition to these nine patients another man had developed ventricular fibrillation during implantation of a previous epicardial pacemaker unit. These five patients were successfully resuscitated and were alive and well at the time of writing.
There was a history of myocardial infarction In eight patients and of generalized ischaemic heart disease in 13. In the remaining 23 no obvious cause was found for the heart block. A basal blood-pressure recording of 160/95 mm. Hg Complications (Table II) These can be divided into early and late features. The early complications occurred while the patient was still in hospitalthat is, within the first 14 postoperative days. They included arrhythmias, movement of the electrode tip, and penetration of the myocardium. Ventricular extrasystoles were observed in the majority of patients when they were monitored carefully in the first 48 hours after the implant. Their frequency gave rise to anxiety in 10 patients. In six of these this complication had also been noted preoperatively, but in the other four they occurred for the first time in the postoperative period. These ventricular extrasystoles were controlled with either procainamide or quinidine, and in eight patients this treatment was continued on leaving hospital. Penetration of the myocardium occurred in two cases, resulting in contractions of the muscles of the chest wall. Thoracotomy was carried out and the catheter withdrawn back into the ventricle and repositioned by manipulation at the neck. The ventricular wall was closed with a single stitch in each case.
The reason for penetration of the myocardium was probably overzealous placing of the electrode tip.
The late complications included breakage of the catheter lead, extrusion of the generator, and generator failure. Breakage of the conducting lead occurred in six patients at the beginning of the series and was due to leaving one of the steel stylets inside the catheter. This was done on the manufacturer's instructions to provide increased catheter stiffness. These pacemakers were replaced, and subsequently both stylets have been withdrawn after positioning of the catheter and no further breakages have occurred.
One generator was found to be faulty at the time of implantation and was not used. Apart from this only one generator has failed in use to date. This failure occurred six months after insertion and was preceded by a period of rapidly increasing pacemaker rate. The patient unfortunately developed irreversible ventricular fibrillation and died.
The Medtronic generator has two protrusions which house the rate and amplitude controls. In four patients these protrusions eroded through the skin two to eight months after implantation, resulting in infection in three of them. In one patient another pacemaker was inserted on the opposite side; in the remaining three cases the generators were exteriorized and without interruption of pacing each was immersed in a surgical glove filled with a powerful antiseptic (Portex D.C.R.) for 20 minutes, after which the wounds were irrigated with Noxyflex and drained. After removal from the antiseptic the generators were replaced at a new site without further complication.
Deaths (Table III) Six patients in this series died at intervals of from 3 to 22 months after insertion of a pacemaker. Four of these units were recovered at post-mortem examination, and in two cases no faults were found in the generators or catheters. The third generator, referred to above, was found to be faulty; the fourth generator was functioning perfectly, but the catheter insulation was broken, and it was thought that this damage had been caused at the post-mortem examination. In the remaining two cases the pacemakers were not recovered, but each was reported to be functioning normally up to the time of death.
One of these patients was known to have had sinus interference; he died in hospital after prostatectomy. In this case an electrical death could not be excluded. The other patient died at home after a second myocardial infarction. 
Discussion
Reports on the efficacy and safety of long-term transvenous pacing are now beginning to appear in the literature (Lagergren et al., 1966; Furman et al., 1966; Morris et al., 1967) . The surgical simplicity of implantation lessens the mortality and morbidity in this high-risk and vulnerable group of patients. On the whole, most of the patients in our group were sick and elderly. The majority of them were over 60 years of age, about half had evidence of ischaemic heart disease, and some had a raised diastolic blood pressure. Several patients had had a cardiac arrest, and many had other diseases (Table I) (Zoll and Linenthal, 1963 ; Fort and Sharp, 1965; Furman, 1966 So far, of the 53 Medtronic generators which we have implanted since October 1964 only one has failed. Thirtythree have been in use for more than six months (see bar Chart) without failure. To date, our duration of pacing has not taken the majority of our patients into the phase of normal battery depletion. We have, however, had no generator or catheter failures since May 1966. In an attempt to monitor the function of the generators we have been recording the pacemaker rate at intervals of two to three months. We also hope that the measurement of generator pulse characteristics will provide a more accurate estimate of battery depletion. However, measurement of pacemaker rate may be an equally reliable index of battery function.
Twelve patients in this series presented with a diagnosis of intermittent complete heart block. They were also treated with the standard fixed-rate pacemaker, and 11 were alive and well at the time of writing. The remaining patient died after prostatectomy. In other words, patients with intermittent block in this series were satisfactorily treated with a fixed-rate pacemaker. There may, however, be a case for using a "demand pacemaker in younger patients.
It is our experience that the Medtronic endocardial implantable pacemaker is reliable and offers an effective remedy for chronic complete heart block. This is also the finding of other workers (Castberg and Rasmussen, 1963 ; Marchand et al., 1967 ).
Summary
Forty-four patients with chronic complete heart block have been treated by the insertion of the fixed-rate ChardackGreatbatch endocardial pacemaker.
The preoperative mortality was nil, the postoperative morbidity low.
Of the 53 generators implanted there was one failure (1.9%). There were six catheter failures (11.3%), all at the beginning of the series, owing to a steel stylet being left inside each catheter.
There have been no catheter or generator failures since May 1966.
